Headlines and summaries are written by AI. How it works
The European Commission has granted Daraxonrasib a centralised EU marketing authorisation for adults with metastatic pancreatic cancer who have had prior treatment. National agencies now negotiate reimbursement, and the drug does not cure the disease.